The IL−17-expressing CD4+ helper T cell (Th) subset is significantly involved in immune response signaling pathways, correlating not only with autoimmune diseases but also with cancer progression (Amatya et al., 2017). This evidence concerns the gene IL17A and autoimmune disease.